Редактирование: COCH

Cochlin precursor (COCH-5B2) [COCH5B2] [UNQ257/PRO294]

==Publications==

{{medline-entry
|title=Hearing and vestibular deficits in the Coch(-/-) null mouse model: comparison to the Coch(G88E/G88E) mouse and to DFNA9 hearing and balance disorder.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/21073934
|abstract=Two mouse models, the Coch(G88E/G88E) or "knock-in" and the Coch(-/-) or "knock-out" (Coch null), have been developed to study the human late-onset, progressive, sensorineural hearing loss and vestibular dysfunction known as DFNA9. This disorder results from missense and in-frame deletion mutations in [[COCH]] (coagulation factor C homology), encoding cochlin, the most abundantly detected protein in the inner ear. We have performed hearing and vestibular analyses by auditory brainstem response ([[ABR]]) and vestibular evoked potential (VsEP) testing of the Coch(-/-) and Coch(G88E/G88E) mouse models. Both Coch(-/-) and Coch(G88E/G88E) mice show substantially elevated [[ABR]]s at 21 months of age, but only at the highest frequency tested for the former and all frequencies for the latter. At 21 months, 9 of 11 Coch(-/-) mice and 4 of 8 Coch(G88E/G88E) mice have absent [[ABR]]s. Interestingly Coch(-/ ) mice do not show hearing deficits, in contrast to Coch(G88E/ ), which demonstrate elevated [[ABR]] thresholds similar to homozyotes. These results corroborate the DFNA9 autosomal dominant mode of inheritance, in addition to the observation that haploinsufficiency of Coch does not result in impaired hearing. Vestibular evoked potential (VsEP) thresholds were analyzed using a two factor ANOVA (Age X Genotype). Elevated VsEP thresholds are detected in Coch(-/-) mice at 13 and 21 months, the two ages tested, and as early as seven months in the Coch(G88E/G88E) mice. These results indicate that in both mouse models, vestibular function is compromised before cochlear function. Analysis and comparison of hearing and vestibular function in these two DFNA9 mouse models, where deficits occur at such an advanced age, provide insight into the pathology of DFNA9 and age-related hearing loss and vestibular dysfunction as well as an opportunity to investigate potential interventional therapies.
|mesh-terms=* Acoustic Stimulation
* Age Factors
* Aging
* Analysis of Variance
* Animals
* Auditory Threshold
* Cochlea
* Disease Models, Animal
* Evoked Potentials, Auditory, Brain Stem
* Extracellular Matrix Proteins
* Gene Knock-In Techniques
* Genotype
* Hearing
* Hearing Loss, Sensorineural
* Mice
* Mice, Inbred CBA
* Mice, Knockout
* Phenotype
* Postural Balance
* Proteins
* Vestibular Diseases
* Vestibular Evoked Myogenic Potentials
* Vestibule, Labyrinth

|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039082
}}